查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1595564

早洩治療市場：按藥物類型、劑型、分銷管道分類 - 全球預測 2025-2030

Premature Ejaculation Treatment Market by Drug Type (Dapoxetine, Phosphodiesterase Type 5 Inhibitors, Selective Serotonin Reuptake Inhibitors), Type, Dosage Form, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年早洩治療市場規模為35.2億美元，預計2024年將達38.6億美元，複合年成長率為9.80%，2030年將達67.7億美元。

早洩 (PE) 治療市場包括多種旨在管理或解決這種常見男性性功能障礙的產品和治療方法。 PE 的定義是射精發生得比預期早，可能會導致痛苦和人際關係問題，凸顯了有效介入的必要性。治療方法包括從口服藥物解決方案（如 SSRIs）到行為療法和局部麻醉劑，以解決身體和心理的方面。主要最終用戶包括醫療保健提供者以及尋求臨床建議和非處方藥的不同年齡層的男性。該市場的主要成長動力包括健康意識的提高、藥品的進步以及社會的轉變以更公開地討論男性性健康。技術進步和研發措施為開發創新治療方法和個人化醫療保健解決方案提供了肥沃的土壤。特別是，遠端醫療和電子商務平台的出現正在擴大治療範圍，並為市場參與者創造新的機會。然而，恥辱感、低度開發地區消費者缺乏意識以及治療潛在副作用等限制因素繼續挑戰著成長。監管障礙和大規模臨床試驗的需要也減緩了新藥的推出。在創新方面，個人化醫療和人工智慧的整合以實現更好的診斷和治療客製化是有前途的。對非侵入性治療和自然療法的探索提供了潛在的創新途徑。競爭格局充滿活力，既有成熟的製藥巨頭，也有靈活的新興企業，反映了強勁但複雜的市場特徵。尋求擴張的公司應利用數位平台擴大對消費者的影響力，並參與研發合作以維持長期成長。透過提高認知宣傳活動解決教育障礙並消除疾病污染可以進一步提高市場滲透率和消費者參與。

主要市場統計
基準年[2023] 35.2億美元
預測年份 [2024] 38.6億美元
預測年份 [2030] 67.7億美元
複合年成長率（%） 9.80%

市場動態：揭示快速發展的早洩治療市場的關鍵市場洞察

供需的動態交互作用正在改變早洩治療市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 提高政府對早洩的認知
    • 早洩盛行率增加
    • 透過遠端醫療進行治療的可能性
  • 市場限制因素
    • 與早洩治療相關的副作用
  • 市場機會
    • 增加治療藥物的研發
    • 增加策略聯盟以開發新的診斷工具
  • 市場挑戰
    • 醫護人員短缺

波特的五力策略工具駕馭早洩治療市場

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解早洩治療市場的外在影響

外在宏觀環境因素對早洩治療市場的表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解早洩治療市場的競爭狀況

對早洩治療市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣早洩治療市場供應商的績效評估

FPNV定位矩陣是評估早洩治療市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，以規劃早洩治療市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對早洩治療市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 意識提升
      • 早洩增加
      • 透過遠端醫療進行治療的可用性
    • 抑制因素
      • 與早洩治療相關的副作用
    • 機會
      • 增加治療藥物的研發
      • 加強策略合作開發新診斷工具
    • 任務
      • 醫護人員短缺
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 早洩治療市場藥物按類型

  • 達泊西汀
  • 5 型磷酸二酯酶 (PDE5) 抑制劑
  • 選擇性血清素再回收抑制劑
  • 局部麻醉劑
  • 澤爾坦

第7章早洩治療市場：依類型

  • 口腔治療
    • 非選擇性血清素再回收抑制劑
    • 選擇性血清素再回收抑制劑
  • 局部治療

第8章早洩治療市場（以劑型）

  • 錠劑
  • 噴

第9章早洩治療市場：依通路分類

  • 醫院
  • 網路藥房
  • 零售藥房

第10章北美及南美早洩治療市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區早洩治療市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東和非洲的早洩治療市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Ampio Pharmaceuticals, Inc.
  • Aytu BioPharma, Inc.
  • Bayer AG
  • Donga Pharmaceutical Co.,Ltd.
  • Eli Lilly and Company
  • Emcure Pharmaceuticals
  • Futura Medical PLC
  • GlaxoSmithKline PLC
  • Hetero Healthcare Limited
  • Menarini Group
  • NeuroHealing Pharmaceuticals Inc.
  • Pfizer Inc.
  • Veru Inc.
  • Wholesome Medtech Private Limited
  • zr pharma& GmbH
Product Code: MRR-030EE48515EB

The Premature Ejaculation Treatment Market was valued at USD 3.52 billion in 2023, expected to reach USD 3.86 billion in 2024, and is projected to grow at a CAGR of 9.80%, to USD 6.77 billion by 2030.

The treatment market for premature ejaculation (PE) encompasses a wide array of products and therapies aimed at managing or resolving this common male sexual dysfunction. Defined as ejaculation that occurs sooner than desired, PE can lead to distress and interpersonal issues, underlining the necessity for effective interventions. Treatments range from oral pharmacological solutions like SSRIs to behavioral therapies and topical anesthetics, catering to both physical and psychological facets. The primary end-users include men across various age groups seeking clinical advice or over-the-counter options, alongside healthcare providers. Key growth drivers in this market involve increasing health awareness, advancements in pharmaceuticals, and the societal shift towards more open discussions on male sexual health. Technological advancements and R&D initiatives provide fertile ground for developing innovative treatment modalities and personalized healthcare solutions. In particular, the advent of telemedicine and e-commerce platforms has expanded access to treatments, creating new opportunities for market players. However, limitations such as stigma, lack of consumer awareness in less developed regions, and potential side effects of treatments continue to challenge growth. Regulatory hurdles and the need for extensive clinical trials can also delay the introduction of new drugs. In terms of innovation, personalized medicine and integrating artificial intelligence for better diagnosis and therapy customization hold promise. Exploration in non-invasive treatments and natural therapies offers potential innovation routes. The competitive landscape is pulsating with activities from both established pharmaceutical giants and nimble startups, reflecting a robust but intricate market nature. Companies eager to expand should leverage digital platforms to enhance consumer reach and engage in collaborations for R&D to sustain long-term growth. Addressing educational barriers and destigmatizing the condition through awareness campaigns can further enhance market penetration and consumer engagement.

KEY MARKET STATISTICS
Base Year [2023] USD 3.52 billion
Estimated Year [2024] USD 3.86 billion
Forecast Year [2030] USD 6.77 billion
CAGR (%) 9.80%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Premature Ejaculation Treatment Market

The Premature Ejaculation Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Raising governments awareness of premature ejaculation
    • Increasing prevalence of premature ejaculation
    • Availability of treatment through telehealth
  • Market Restraints
    • Side effects associated with the premature ejaculation treatment
  • Market Opportunities
    • Rising research & development of drugs for treatment
    • Increasing strategic collaborations for development of new diagnostic tools
  • Market Challenges
    • Shortage of medical professionals

Porter's Five Forces: A Strategic Tool for Navigating the Premature Ejaculation Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Premature Ejaculation Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Premature Ejaculation Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Premature Ejaculation Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Premature Ejaculation Treatment Market

A detailed market share analysis in the Premature Ejaculation Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Premature Ejaculation Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Premature Ejaculation Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Premature Ejaculation Treatment Market

A strategic analysis of the Premature Ejaculation Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Premature Ejaculation Treatment Market, highlighting leading vendors and their innovative profiles. These include Ampio Pharmaceuticals, Inc., Aytu BioPharma, Inc., Bayer AG, Donga Pharmaceutical Co.,Ltd., Eli Lilly and Company, Emcure Pharmaceuticals, Futura Medical PLC, GlaxoSmithKline PLC, Hetero Healthcare Limited, Menarini Group, NeuroHealing Pharmaceuticals Inc., Pfizer Inc., Veru Inc., Wholesome Medtech Private Limited, and zr pharma& GmbH.

Market Segmentation & Coverage

This research report categorizes the Premature Ejaculation Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Drug Type, market is studied across Dapoxetine, Phosphodiesterase Type 5 (PDE5) Inhibitors, Selective Serotonin Reuptake Inhibitors, Topical Anesthetics, and Zertane.
  • Based on Type, market is studied across Oral Therapies and Topical Therapies. The Oral Therapies is further studied across Nonselective Serotonin Reuptake Inhibitor and Selective Serotonin Reuptake Inhibitor.
  • Based on Dosage Form, market is studied across Pills and Spray.
  • Based on Distribution Channel, market is studied across Hospitals, Online Pharmacies, and Retail Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Raising governments awareness of premature ejaculation
      • 5.1.1.2. Increasing prevalence of premature ejaculation
      • 5.1.1.3. Availability of treatment through telehealth
    • 5.1.2. Restraints
      • 5.1.2.1. Side effects associated with the premature ejaculation treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising research & development of drugs for treatment
      • 5.1.3.2. Increasing strategic collaborations for development of new diagnostic tools
    • 5.1.4. Challenges
      • 5.1.4.1. Shortage of medical professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Premature Ejaculation Treatment Market, by Drug Type

  • 6.1. Introduction
  • 6.2. Dapoxetine
  • 6.3. Phosphodiesterase Type 5 (PDE5) Inhibitors
  • 6.4. Selective Serotonin Reuptake Inhibitors
  • 6.5. Topical Anesthetics
  • 6.6. Zertane

7. Premature Ejaculation Treatment Market, by Type

  • 7.1. Introduction
  • 7.2. Oral Therapies
    • 7.2.1. Nonselective Serotonin Reuptake Inhibitor
    • 7.2.2. Selective Serotonin Reuptake Inhibitor
  • 7.3. Topical Therapies

8. Premature Ejaculation Treatment Market, by Dosage Form

  • 8.1. Introduction
  • 8.2. Pills
  • 8.3. Spray

9. Premature Ejaculation Treatment Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Hospitals
  • 9.3. Online Pharmacies
  • 9.4. Retail Pharmacies

10. Americas Premature Ejaculation Treatment Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Premature Ejaculation Treatment Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Premature Ejaculation Treatment Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Ampio Pharmaceuticals, Inc.
  • 2. Aytu BioPharma, Inc.
  • 3. Bayer AG
  • 4. Donga Pharmaceutical Co.,Ltd.
  • 5. Eli Lilly and Company
  • 6. Emcure Pharmaceuticals
  • 7. Futura Medical PLC
  • 8. GlaxoSmithKline PLC
  • 9. Hetero Healthcare Limited
  • 10. Menarini Group
  • 11. NeuroHealing Pharmaceuticals Inc.
  • 12. Pfizer Inc.
  • 13. Veru Inc.
  • 14. Wholesome Medtech Private Limited
  • 15. zr pharma& GmbH

LIST OF FIGURES

  • FIGURE 1. PREMATURE EJACULATION TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. PREMATURE EJACULATION TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. PREMATURE EJACULATION TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. PREMATURE EJACULATION TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PREMATURE EJACULATION TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PREMATURE EJACULATION TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DAPOXETINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHOSPHODIESTERASE TYPE 5 (PDE5) INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TOPICAL ANESTHETICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ZERTANE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY NONSELECTIVE SEROTONIN REUPTAKE INHIBITOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TOPICAL THERAPIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PILLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SPRAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 235. PREMATURE EJACULATION TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 236. PREMATURE EJACULATION TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023